History
  • No items yet
midpage
August Bogina, III v. Medline Industries, Incorpora
809 F.3d 365
7th Cir.
2016
Read the full case

Background

  • Plaintiff Bogina filed a 2011 qui tam False Claims Act (FCA) suit against Medline Industries and the Tutera Group alleging Medline paid bribes/kickbacks to induce purchases by Tutera, causing false claims for government reimbursement.
  • Medline previously faced a similar FCA action brought by employee Sean Mason; that suit settled with Medline paying $85 million and Mason receiving a qui tam share; the government released certain civil claims through May 31, 2010.
  • Bogina contended he was an "original source" who learned of Tutera-specific kickbacks from a Tutera insider and alleged the fraud extended to Medicare Part B, TRICARE, and state Medicaid beyond the scope of the Mason litigation.
  • The district court dismissed Bogina’s federal claims as barred by the FCA public-disclosure/original-source rules because his allegations largely duplicated publicly disclosed allegations in the Mason matter, and then declined supplemental jurisdiction over state-law claims.
  • The Seventh Circuit affirmed, finding Bogina’s complaint did not materially add to prior public disclosures and that continuing-fraud allegations pleaded "on information and belief" failed Rule 9(b) particularity requirements.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Bogina’s FCA claims are barred by public-disclosure/original-source rules Bogina claimed he was an original source with independent knowledge (learned from Tutera insider) and added allegations not in Mason Medline argued Mason’s public complaint and settlement publicly disclosed the same scheme, so Bogina is a "me too" relator and not an original source Court held Bogina’s allegations did not materially add to public disclosures; suit barred absent original-source status
Whether the 2010 amendment to the original-source definition applies Bogina argued the clarified (2010) definition should govern and he meets it Medline relied on pre-2010 public disclosures and prior cases treating timing as limiting Court treated the 2010 amendment as clarifying subsection (B) and applied its standard (knowledge independent of and materially adding to public disclosures) to reject Bogina’s claim
Whether differences (naming Tutera, additional programs, alleged continuation past 2010) saved the complaint Bogina emphasized naming Tutera, coverage of other programs, and alleged ongoing fraud Medline argued those differences were immaterial because nursing-home sales were already publicly known and settlement put government on notice of broader possibilities Court held those distinctions were unimpressive and did not materially add to prior disclosures
Adequacy of pleading continuing fraud (Rule 9(b)) Bogina alleged the fraud continued to present but pleaded it "on information and belief" Medline argued Rule 9(b) requires particularized factual allegations, and information-and-belief pleading is insufficient for fraud claims Court held continuing-fraud allegations pleaded on information-and-belief lacked required particularity and could not save the complaint

Key Cases Cited

  • United States ex rel. Goldberg v. Rush University Medical Center, 680 F.3d 933 (7th Cir. 2012) (discusses limits on duplicate qui tam suits and public-disclosure bar)
  • Glaser v. Wound Care Consultants Inc., 570 F.3d 907 (7th Cir. 2009) (analyzes original-source and public-disclosure doctrines)
  • United States ex rel. Gear v. Emergency Medical Associates of Illinois, Inc., 436 F.3d 726 (7th Cir. 2006) (public-disclosure bar discussion)
  • Leveski v. ITT Educational Services, Inc., 719 F.3d 818 (7th Cir. 2013) (interpretation of pre-2010 original-source language)
  • Middleton v. City of Chicago, 578 F.3d 655 (7th Cir. 2009) (retroactivity principles for statutory clarification)
  • Graham County Soil & Water Conservation Dist. v. United States ex rel. Wilson, 559 U.S. 280 (2010) (construed 2010 amendment as non-retroactive where substantive change occurred)
  • United States ex rel. Grenadyor v. Ukrainian Village Pharmacy, Inc., 772 F.3d 1102 (7th Cir. 2014) (Rule 9(b) particularity applied to FCA continuing-fraud allegations)

Outcome: Affirmed dismissal of federal FCA claims; district court properly relinquished supplemental state-law claims.

Read the full case

Case Details

Case Name: August Bogina, III v. Medline Industries, Incorpora
Court Name: Court of Appeals for the Seventh Circuit
Date Published: Jan 4, 2016
Citation: 809 F.3d 365
Docket Number: 15-1867
Court Abbreviation: 7th Cir.